{"id":"NCT03418545","sponsor":"Allergan","briefTitle":"A Safety and Effectiveness of VOLBELLA XC Hyaluronic Acid (HA) Injectable Gel to Correct Infraorbital Hollowing","officialTitle":"A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel for Correction of Infraorbital Hollowing","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-01-26","primaryCompletion":"2018-10-17","completion":"2019-08-22","firstPosted":"2018-02-01","resultsPosted":"2021-11-15","lastUpdate":"2021-11-15"},"enrollment":163,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Infraorbital Hollowing"],"interventions":[{"type":"DEVICE","name":"JUVÉDERM VOLBELLA® XC injectable gel","otherNames":[]}],"arms":[{"label":"JUVÉDERM VOLBELLA® XC","type":"EXPERIMENTAL"},{"label":"No-treatment Control","type":"NO_INTERVENTION"}],"summary":"The objective of this study is to evaluate the safety and effectiveness of JUVÉDERM® VOLBELLA™ XC in adult participants seeking correction of hollowing of the tear troughs.","primaryOutcome":{"measure":"Percentage of Participants With at Least a 1-point Improvement Change From Baseline on the Allergan Infraorbital Hollows Scale (AIHS) Based on Evaluating Investigator's (EI) Assessment","timeFrame":"Baseline (Screening) to Month 3 post last treatment (JUVÉDERM® VOLBELLA™ XC arm) or Month 3 post randomization (No-treatment Control arm)","effectByArm":[{"arm":"No-treatment Control","deltaMin":15.6,"sd":null},{"arm":"JUVÉDERM® VOLBELLA™ XC","deltaMin":83.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"22 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":11},"locations":{"siteCount":15,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.allerganclinicaltrials.com/"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":34},"commonTop":["Injection site bruising","Injection site swelling"]}}